昆士兰大学与昆士兰州政府和美国主要慈善组织大西洋慈善基金会合作，在皇家布里斯班妇女医院（RBWH）开发了耗资7000万澳元的昆士兰大学临床研究中心（CCR）。
研究所专注于通过以患者为导向的研究来改善人们的生活，提供最先进的设施，并汇集了来自世界各地的领先卫生专业人员、临床医生和科学家。
“以患者为导向的研究”是指针对医疗保健环境中出现的问题进行的研究。这使研究人员能够为患者提供更好的治疗和结果，并增加有关特定疾病或问题的知识体系。
该研究所的使命是通过卓越的研究、临床合作、指导和服务来改善健康。研究所希望成为创新和多学科合作临床研究的全球领导者。提供出色的研究指导和培训。让社区、卫生部门和行业的合作伙伴参与进来，制定和提供有效的医疗保健干预措施。向社区提供健康教育和科学意识。通过循证宣传制定健康和资助政策。
在研究癌症领域，研究所的研究计划联合了20名澳大利亚和7名国际肿瘤学家，并研究了全球760名患者。
研究人员比较了两种不同的手术技术：腹腔开放手术和微创手术（MIS）。MIS患者的术后并发症显著减少，术后6周和6个月生活质量显著改善。这项工作为全球34项指南提供了信息，并直接促进了临床实践和卫生政策的变化，提高了全球癌症患者的生存率。
The University of Queensland has partnered with the Queensland Government and the Atlantic Philanthropic Foundation, a major US charitable organisation, to develop the $70 million UQ Clinical Research Centre (CCR) at the Royal Brisbane Women's Hospital (RBWH).
Focused on improving people's lives through patient-oriented research, the Institute offers state-of-the-art facilities and brings together leading health professionals, clinicians and scientists from around the world.
"Patient-oriented research" refers to research that addresses issues that arise in a healthcare setting. This allows researchers to provide better treatments and outcomes to patients and increase the body of knowledge about specific diseases or problems.
The Institute's mission is to improve health through excellence in research, clinical collaboration, mentorship, and service. The Institute aspires to be a global leader in innovative and multidisciplinary collaborative clinical research. Provide excellent research guidance and training. Engage community, health sector and industry partners to develop and deliver effective healthcare interventions. Provide health education and scientific awareness to the community. Develop health and funding policies through evidence-based advocacy.
In the field of research cancer, the Institute's research programme unites 20 Australian and 7 international oncologists and studies 760 patients worldwide.
The researchers compared two different surgical techniques: open abdominal surgery and minimally invasive surgery (MIS). Patients with MIS had significantly fewer postoperative complications and a significant improvement in quality of life at 6 weeks and 6 months postoperatively. This work informed 34 guidelines worldwide and directly contributed to changes in clinical practice and health policy, improving survival for cancer patients worldwide.